BioSpace News Archive

Business

Spago Nanomedical Publishes the Annual Report for 2022

Spago Nanomedical’s annual report for 2022 is from available at the company’s website.

March 29, 2023
·
1 min read
Pharm Country

PDS Biotech to Participate in Cantor’s Future of Oncology Virtual Symposium

PDS Biotechnology Corporation today announced that Dr. Frank Bedu-Addo, President and Chief Executive Officer, will participate in Cantor’s Future of Oncology Virtual Symposium being held on April 3-5, 2023.

March 29, 2023
·
1 min read
BioMidwest

Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2022 and provided an update on progress toward achieving key corporate objectives.

March 29, 2023
·
10 min read
Business

Kristin Stafford Joins Novocure Board of Directors

Novocure (NASDAQ: NVCR) today announced that Kristin Stafford has been elected to Novocure’s Board of Directors.

March 29, 2023
·
3 min read
Genetown

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced initial pipeline programs focused on diseases that originate in the liver.

March 29, 2023
·
11 min read
Business

Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

Kala Pharmaceuticals, Inc. today announced the appointment of Francis Mah, M.D., as Chief Medical Advisor.

March 29, 2023
·
7 min read
Business

CRISPR Therapeutics Announces Departure of Board Member

CRISPR Therapeutics today announced that Brad Bolzon, Ph.D., Chairman and Managing Director of Versant Ventures, is stepping down from the Board of Directors after nearly a decade of service.

March 29, 2023
·
2 min read
Biotech Bay

Vaxart to Present at World Vaccine Congress Washington 2023 on April 5-6

Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will make presentations at the World Vaccine Congress Washington 2023 in Washington, D.C. on Wednesday, April 5 and Thursday, April 6, 2023.

March 29, 2023
·
1 min read
Business

Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs

Cocrystal Pharma, Inc. (Nasdaq: COCP) reports financial results for the 12 months ended December 31, 2022, and provides updates on its antiviral pipeline, upcoming milestones and business activities.

March 29, 2023
·
15 min read
Business

IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023

IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense System of minimally-invasive cryoablation technology that destroys tumors by freezing, today reported audited financial results as of and for the twelve months ended December 31, 2022.

March 29, 2023
·
14 min read